We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HROWL market cap is 904.2M. The company's latest EPS is USD -0.6854 and P/E is -37.04.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 33.47M | 34.27M | 36.36M | 34.59M | 48.94M |
Operating Income | 2.2M | 1.74M | -4.88M | -6.93M | 1.53M |
Net Income | -4.23M | -4.39M | -9.15M | -13.57M | -6.47M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 51.17M | 48.87M | 72.48M | 88.6M | 130.19M |
Operating Income | -763k | 385k | 1.61M | -9.21M | 431k |
Net Income | 168k | -3.36M | -18.01M | -14.09M | -24.41M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 223.99M | 286.07M | 312.16M | 295.54M | 306.63M |
Total Liabilities | 201.94M | 210.66M | 241.75M | 235.33M | 248.45M |
Total Equity | 22.05M | 75.4M | 70.41M | 60.21M | 58.18M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 59.09M | 57.47M | 98.33M | 157.38M | 312.16M |
Total Liabilities | 31.67M | 30.65M | 87.4M | 130.14M | 241.75M |
Total Equity | 27.42M | 26.83M | 10.93M | 27.24M | 70.41M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -3.65M | -4.86M | 3.84M | -4.63M | -7.37M |
Investing | -132.22M | -152.35M | -152.55M | -110k | 4.99M |
Financing | 62.35M | 126.55M | 126.53M | -809k | -736k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 950k | -1.1M | 5.08M | 1.71M | 3.84M |
Investing | -1.83M | -981k | -18.69M | -1.74M | -152.55M |
Financing | -1.01M | 1.43M | 51.47M | 54.14M | 126.53M |
Market Cap | 904.2M |
Price to Earnings Ratio | -37.04 |
Price to Sales Ratio | 6.95 |
Price to Cash Ratio | 12.21 |
Price to Book Ratio | 12.84 |
Dividend Yield | 8.49% |
Shares Outstanding | 35.61M |
Average Volume (1 week) | 3.29k |
Average Volume (1 Month) | 3.31k |
52 Week Change | 5.79% |
52 Week High | 25.73 |
52 Week Low | 23.70 |
Spread (Intraday) | 0.21 (0.83%) |
Company Name | Harrow Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.harrow.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions